PSM Statement on the passage of S.3201, which extends the DEA’s temporary scheduling of fentanyl-related substances as Schedule I for 15 months.

The Partnership for Safe Medicines (PSM) stands with our law enforcement partners in commending the U.S. Senate and the U.S. House of Representatives for their swift passage of S.3201, which would extend the DEA’s temporary scheduling of fentanyl-related substances to be Schedule I controlled substances for an additional 15 months. Without this reauthorization, criminals could…

[...]

HHS Announces Dangerous Draft Regulations for Importing Drugs from Canada

Partnership for Safe Medicines Statement on Proposed Regulations to Import Prescription Medicines from Canada Washington, D.C. (December 18, 2019) – Shabbir Safdar, executive director of the Partnership for Safe Medicines, released the following statement in response to today’s announcement by the Trump Administration and the proposed regulations to allow importation of prescription medicines: “Citizens of…

[...]

Motto International Corp. Issues Voluntary Recall of Bull Platinum 30000, Stallion Platinum 30000, Rhino 7 Platinum 30000, and Panther Platinum 30000, Due to Presence of Undeclared Tadalafil

Consumption of a product with undeclared tadalafil may pose a risk to consumers who take prescription medications containing nitrates (such as nitroglycerin). The combination of tadalafil and nitrates may lower blood pressure to dangerous levels which can be life threatening. Consumers with diabetes, high blood pressure, high cholesterol, or heart disease often take nitrates and may be the population most likely to be affected.

[...]